FindTrial
Sign In

Effects of Baduanjin on Traditional Chinese Medicine Syndrome Type Scores and Neurofilament Light Chain Protein in Hemodialysis Patients with Mild Cognitive Impairment

Effects of Baduanjin on Traditional Chinese Medicine Syndrome Type Scores and Neurofilament Light Chain Protein in Hemodialysis Patients with Mild Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001754
Enrollment
Unknown
Registered
2026-07-16
Start date
2024-01-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease

Interventions

Baduanjin group:Baduanjin
control group:maintain original lifestyle habits.

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for mild cognitive impairment. Undergo regular hemodialysis for =3 months; age =18 years. NYHA cardiac function class I or II. Patient provides informed consent.

Exclusion criteria

Exclusion criteria: Diagnosed with dementia or psychiatric disorders. Currently or chronically taking medications that affect cognitive function. Unstable cardiac function, such as uncontrolled arrhythmia. Unable to perform exercise due to joint deformity, limb disability, or visual impairment. Unable to take BCM examination

Design outcomes

Primary

MeasureTime frame
Cognitive function score;Nfl;—

Secondary

MeasureTime frame
TCM syndrome score;—

Countries

China

Contacts

Public Contactyuelin wang

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University

15869136978@163.com15869136978

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026